Episode 23: Garen Staglin, founder of One Mind on investing in mental health treatment innovation.


Garen K. Staglin is a private equity and venture capital investor, mental health advocate, and owner of the acclaimed Staglin Family Vineyard, in Rutherford, Napa Valley, California. He has been involved in companies in the transaction processing services and payment technology industries for more than 30 years. He currently serves as Chairman of ExL Services (EXLS), and Board memebr of SVB Financial Group (SIVB), NVoice Payments, Profit Velocity Solutions and Specialized Bicycle Corp. He and his wife founded the International Mental Health Research organization (www.imhro.org ) in 1995 and have raised over $200 Million to find the causes and cures for mental illness. In 2009, together with actress Glen Close, they founded BringChange2Mind.org (www.bringchange2mind.org “BC2M”) to raise awareness and decrease stigma for people who suffer from mental illness. In 2010, he and Congressman Patrick Kennedy created and founded the One Mind for Research Campaign (www.oneind.org ) where he serves as Co-Chairman. He is also a Senior Advisor to FTV Capital, LLC. Previously, Staglin was CEO of eONE Global, L.P., Safelite Auto Glass, Group President of ADP Automotive Services Group (ADP) as well a Director of First Data Corp. (FDC), CyberCash (CYCH), Quick Response Systems (QRS), Solera Holdings (SLH), Bottomline Technologies (EPAY) and a Senior Advisor at Irving Place Capital. He has also served as a member of the Advisory Board at the Stanford Graduate School of Business, the UCLA Venture Capital Fund, and the Cambridge University Judge Business School in the United Kingdom. He also serves as the Co-Chairman of the UCLA Centennial Campaign. Mr. Staglin holds a B.S. in engineering from University of California, Los Angeles and an M.B.A. from The Graduate School of Business at Stanford.

Embed Block
Add an embed URL or code. Learn more
Previous
Previous

Episode 24: Arden O’Connor of O’Conner Professional Group on behavioral health treatment programs efficacy.

Next
Next

Episode 22: John MacPhee, CEO of the Jed Foundation on suicide prevention.